Kiniksa Pharmaceuticals

Kiniksa Pharmaceuticals is a global biopharmaceutical company dedicated to developing and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs. Their focus is on immune-modulating assets that target a spectrum of underserved cardiovascular and autoimmune conditions. Kiniksa's commitment to patients is evident in their patient-centric approach, with programs like Kiniksa OneConnect providing personalized support throughout the treatment journey. They also prioritize ethical practices, evidenced by their robust compliance and ethics program, as well as their commitment to patient advocacy and community engagement.

Kiniksa's pipeline consists of several clinical-stage product candidates with the potential for differentiation. Their flagship product, ARCALYST, is FDA-approved for recurrent pericarditis, cryopyrin-associated periodic syndromes (CAPS), and deficiency of the interleukin-1 receptor antagonist (DIRA). They are also advancing the development of abiprubart, an anti-CD40 monoclonal antibody, for the treatment of Sjögren's Disease. Furthermore, they are actively seeking partnerships to expand their pipeline and advance their mission of delivering life-changing therapies to patients.

Kiniksa Pharmaceuticals offers a variety of flexible work options, including remote work opportunities and a generous paid time off policy. The company also provides a comprehensive benefits package that includes parental leave, an employee assistance program, and a robust 401(k) plan with company match. This allows employees to strike a balance between work and personal life, fostering a healthy and supportive work environment.

Kiniksa Pharmaceuticals offers a comprehensive benefits package to its US employees, including competitive salaries, health insurance with a generous company contribution, a 401(k) plan with a company match, an employee stock purchase plan, flexible spending accounts, life insurance, short- and long-term disability insurance, paid vacation and sick time, and company holidays. They also offer employee referral bonuses, an employee assistance program, and paid parental leave.

Kiniksa Pharmaceuticals is a global biopharmaceutical company dedicated to developing and commercializing innovative therapies for patients suffering from debilitating diseases with significant unmet medical needs. Their mission focuses on discovering and delivering novel treatments, primarily through immune modulation, to improve the lives of individuals facing underserved conditions and to provide them with life-changing medicines.

Kiniksa Pharmaceuticals emphasizes a patient-centric culture, promoting a collaborative and supportive environment where highly skilled and passionate individuals can thrive. They are dedicated to creating a culture of equality that celebrates diversity, fosters innovation, and prioritizes integrity in every action. This commitment is reflected in their benefits package, which includes competitive salaries, robust health insurance, a 401(k) plan with a company match, and parental leave. The company also fosters employee engagement through a focus on employee well-being, diversity, equity, and inclusion, and through participation in various community events and initiatives.

Kiniksa Pharmaceuticals is committed to fostering a diverse, equitable, and inclusive workplace. They believe that a culture that celebrates diversity and inclusion drives innovation and delivers on the promise of transformative therapies to patients. They are dedicated to providing equal opportunities for all employees, regardless of race, color, religion, sex, gender identity, gender expression, national origin, ancestry, ethnicity, citizenship, age, physical or mental disability, transgender status, military or veteran status, marital status, domestic partner status, sexual orientation, genetic information, or any other basis protected by applicable laws.